Prosecution Insights
Last updated: November 20, 2026

Walter E Webb, USPTO Patent Examiner

Listed by the USPTO as WEBB, WALTER E

Tech Center 1600 • Art Units: 1600 1612 1658

This examiner grants 46% of resolved cases

Analysis

WEBB, WALTER E examines in tech center 1600 and art unit 1600. The record covers 1007 resolved cases, with a 46.2% allowance rate and a median of 1215 days to allowance. The 18.9% interview lift is positive, indicating an association between interviews and improved allowance outcomes in the reported matters.

The listed companies are L'Oréal, Colgate-Palmolive Company, and The Procter & Gamble Company. The principal firms are Casimir Jones, S.C., OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., and The Marbury Law Group, PLLC. The substantial case base supports using the profile for planning, while the below-majority allowance rate and extended median timeline favor early claim differentiation, fallback positions, and disciplined interview preparation.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

46.2%
Allow Rate
-13.8% vs TC avg
1,068
Total Applications
+18.9%
Interview Lift
1215
Avg Prosecution Days
Based on 1007 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
14.7%
§102 Novelty
52.2%
§103 Obviousness
16.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18941686 METHOD OF TREATING TEETH USING AN ORAL CARE ARTICLE COMPRISING A DELIVERY CARRIER AND SOLID HYDROPHILIC PARTICLES Non-Final OA The Procter & Gamble Company
18886278 Oral Care Compositions With Anticaries Activity Non-Final OA The Procter & Gamble Company
18788266 Fluoride-Free Anticavity Oral Care Compositions Non-Final OA The Procter & Gamble Company
18713364 METHOD OF PREPARING BIODEGRADABLE MICROCAPSULES BASED ON GELATINE Final Rejection SYNGENTA CROP PROTECTION AG
18413349 OSIMERTINIB FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER Final Rejection ASTRAZENECA AB
18734661 COSMETIC COMPOSITION INCLUDING AN ALOE-TREATED COLORANT Final Rejection L'OREAL
18258011 DYEING COMPOSITION BASED ON 2-GAMMA-HYDROXYPROPYL-PARA-PHENYLENEDIAMINE AND ON A PHOSPHORIC SURFACTANT Final Rejection L'Oreal
18008250 DYEING AND/OR LIGHTENING COMPOSITION COMPRISING AN ANTHRAQUINONE CATIONIC DIRECT DYE, A FATTY SUBSTANCE, A CHEMICAL OXIDIZING AGENT AND A BASIFYING AGENT AND/OR AN OXIDATION DYE PRECURSOR Final Rejection L'Oreal
18293248 COSMETIC COMPOSITION Final Rejection KAO CORPORATION
18643489 Oral Health Composition Comprising Purified Biosurfactants and/or Their Derivatives Final Rejection Locus Solutions IPCo, LLC
17628639 ANTIMICROBIAL COMPOSITIONS Non-Final OA GOJO Industries, Inc.
19044040 Peroxymonosulfate Whitening Strips Non-Final OA Colgate-Palmolive Company
19011108 Oral Care Compositions and Methods of Use Non-Final OA Colgate-Palmolive Company
18808749 Metal Salt Compositions Non-Final OA Colgate-Palmolive Company
18354302 COMPOSITIONS AND RELATED METHODS Final Rejection Colgate-Palmolive Company
18109223 Oral Care Compositions Final Rejection Colgate-Palmolive Company
18006482 Inhibitors of the Artemin Pathway for Treatment of Cancer Final Rejection The University of Chicago
18019634 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE FOR TREATING THROMBOCYTHEMIA Non-Final OA Constellation Pharmaceuticals, Inc.
18020235 METHODS AND COMPOSITIONS FOR TREATING PERIODONTAL DISEASE Non-Final OA University of Louisville Research Foundation, Inc.
18651043 CITRIC ACID AND LACTIC ACID DISINFECTING SOLUTION FOR SOFT POROUS SURFACES Non-Final OA The Clorox Company
18005425 COOLING SENSATION COMPOSITIONS Final Rejection GIVAUDAN SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Walter E Webb's allowance rate?

46.2% of resolved applications examined by Walter E Webb were allowed (1,007 resolved cases), compared with 36.5% across Art Unit 1600 over the last five years.

Does an interview help with examiner Walter E Webb?

This examiner's interview lift is +18.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Walter E Webb take to allow a patent?

Applications allowed by Walter E Webb took 1,215 days on average from filing to allowance.

Which art unit does examiner Walter E Webb work in?

Walter E Webb examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month